FDA NDA · NDA016755

DIAPID

Sponsor: NOVARTIS

APPLICATION

NDA016755

TYPE

NDA

ROUTE

NASAL

DOSAGE FORM

SOLUTION

MARKETING STATUS

Discontinued

Products

DIAPIDDiscontinued

LYPRESSIN 0.185MG/ML · SOLUTION · NASAL

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.